Bregs in murine tumor models and cancer patients have been shown to attenuate antitumor immunity by secreting anti-inflammatory mediators (e.g., IL-10, TGF-β, and IL-35) by suppressing T-cell immune responses and to promote tumor progression by promoting Treg production (85). This evidence concerns the gene TGFB1 and cancer.